- Previous Close
1.0760 - Open
1.1260 - Bid 1.0860 x --
- Ask 1.1180 x --
- Day's Range
1.1360 - 1.1800 - 52 Week Range
0.5960 - 1.3660 - Volume
2,000 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) 0.69
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Mar 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems worldwide. It operates through four segments: HealthCare IT, Digital Print & Chemicals, Radiology Solutions, and CONOPS. The company's CONOPS segment engages in supply of film and chemicals, as well support services. Its Radiology Solutions segment offers analog and digital imaging technology for diagnostic imaging market to meet the needs of specialized clinicians in hospitals and imaging centers; and X-ray film, hardcopy film and printers, digital radiography equipment, and image processing software. The company's Healthcare IT segment provides healthcare's enterprise imaging platform. Its Digital Print & Chemicals segment offers inkjet printers for sign and display and packaging printing companies; inkjet inks and fluids for industrial inkjet applications, such as signs, posters and displays, promotional materials, packaging, leather goods, laminated flooring, and decorative materials, as well as for printed electronics industry; electrolysis membranes to the hydrogen production industry, as well as for printable synthetic papers. This segment also provides films for micrography, non-destructive testing, aerial photography and printed circuit board production; membranes for green hydrogen production; and conductive polymers and materials for the production of high-security ID documents. The company sells its products through its own sales organization, as well as through a network of agents and representatives. Agfa-Gevaert NV was founded in 1867 and is headquartered in Mortsel, Belgium.
www.agfa.com4,819
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: 4AGFB.TI
View MorePerformance Overview: 4AGFB.TI
Trailing total returns as of 1/23/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4AGFB.TI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4AGFB.TI
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-3.28%
Return on Assets (ttm)
-0.31%
Return on Equity (ttm)
-7.59%
Revenue (ttm)
1.13B
Net Income Avi to Common (ttm)
-31M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
69M
Total Debt/Equity (mrq)
43.98%
Levered Free Cash Flow (ttm)
400k